Revolution Medicines, Inc.
RVMDAPI behind this page
RVMD Q1 2026 request
Playground key active
/api/financials?ticker=RVMD&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Research & Development | 343,970 | 205,749 | +67.2% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 343,970 | 205,749 | +67.2% |
| General & Administrative | 101,252 | 35,011 | +189.2% |
| Operating Expenses | 445,222 | 240,760 | +84.9% |
| Operating Income | -445,222 | -240,760 | -84.9% |
| Interest Income | 19,508 | 24,915 | -21.7% |
| Interest Expense | -12,197 | — | — |
| Fair Value Adjustment Of Warrants | -15,788 | 2,439 | -747.3% |
| Other Non-Operating Income (Expense) | 117 | -10 | +1270.0% |
| Non-Operating Income (Expense) | -8,594 | 27,344 | -131.4% |
| Income Before Taxes | -453,816 | -213,416 | -112.6% |
| Net Income | -453,816 | -213,416 | -112.6% |
Show Equity Components breakouts |
|||
| Retained Earnings | -453,816 | -213,416 | -112.6% |
| EPS (Basic) | -2.29 | -1.13 | -102.7% |
| EPS (Diluted) | -2.29 | -1.13 | -102.7% |
| Wtd Avg Shares (Basic) | 198,098,047 | 188,145,904 | +5.3% |
| Wtd Avg Shares (Diluted) | 198,098,047 | 188,145,904 | +5.3% |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -3,851 | 386 | -1097.7% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -3,851 | 386 | -1097.7% |
| Comprehensive Income | -457,667 | -213,030 | -114.8% |
| Net Income Loss Available To Common Stockholders Basic | -453,816 | -213,416 | -112.6% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 440,939 | 333,554 | +32.2% |
| Marketable Securities (Current) | 1,467,145 | 1,769,121 | -17.1% |
| Prepaid Expenses & Other Current Assets | 59,829 | 31,907 | +87.5% |
| Total Current Assets | 1,967,913 | 2,134,582 | -7.8% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 31,475 | 27,153 | +15.9% |
| Operating Lease Right-of-Use Assets | 129,895 | 115,777 | +12.2% |
| Goodwill | 14,608 | 14,608 | 0.0% |
| Restricted Cash Noncurrent | 4,858 | 3,698 | +31.4% |
| Deposits Assets Noncurrent | 34,709 | — | — |
| Other Non-Current Assets | 14,479 | 13,132 | +10.3% |
| Total Assets | 2,253,737 | 2,365,353 | -4.7% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 55,800 | 56,403 | -1.1% |
| Current Liabilities | |||
| Accounts Payable | 80,538 | 47,507 | +69.5% |
| Accrued Expenses And Other Current Liabilities | 192,451 | 98,113 | +96.2% |
| Operating Lease Liability Current | 16,610 | 12,979 | +28.0% |
| Total Current Liabilities | 289,599 | 158,599 | +82.6% |
| Accrued Liabilities | 5 | — | — |
| Non-Current Liabilities | |||
| Deferred Tax Liabilities | 2,353 | 2,353 | 0.0% |
| Operating Lease Liabilities | 140,019 | 121,363 | +15.4% |
| Accrued Royalties Current And Noncurrent | 280,643 | — | — |
| Other Non-Current Liabilities | 6,879 | 4,138 | +66.2% |
| Total Liabilities | 753,820 | 287,203 | +162.5% |
| Other Liabilities | |||
| Warrant Liability | 34,327 | 750 | +4476.9% |
| Stockholders' Equity | |||
| Common Stock | 19 | 18 | +5.6% |
| Additional Paid In Capital Common Stock | 4,823,438 | 4,027,642 | +19.8% |
| Accumulated Other Comprehensive Income | -622 | 1,707 | -136.4% |
| Retained Earnings | -3,322,918 | -1,951,217 | -70.3% |
| Total Stockholders' Equity | 1,499,917 | 2,078,150 | -27.8% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -622 | 1,707 | -136.4% |
| Additional Paid In Capital | 4,823,438 | 4,027,642 | +19.8% |
| Common Stock | 19 | 18 | +5.6% |
| Retained Earnings | -3,322,918 | -1,951,217 | -70.3% |
| Total Liabilities & Equity | 2,253,737 | 2,365,353 | -4.7% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -453,816 | -213,416 | -112.6% |
| Stock-Based Compensation | 87,299 | 25,084 | +248.0% |
| Depreciation Amortization And Accretion Net | 2,346 | 1,692 | +38.7% |
| Paid In Kind Interest | 12,197 | — | — |
| Accretion Amortization Of Discounts And Premiums Investments | -3,223 | -9,817 | +67.2% |
| Operating Lease Right Of Use Asset Amortization Expense | 2,189 | 1,757 | +24.6% |
| Change in Prepaid & Other Assets | -10,471 | 6,426 | -262.9% |
| Change in Accounts Payable | 16,857 | -8,270 | +303.8% |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -16,739 | 1,549 | -1180.6% |
| Increase Decrease In Operating Lease Liability | -2,073 | -1,501 | -38.1% |
| Increase Decrease In Deposit Other Assets | -10,561 | 565 | -1969.2% |
| Increase Decrease In Other Prepaid And Noncurrent Assets | 378 | 200 | +89.0% |
| Change in Other Liabilities | 5,664 | 3,468 | +63.3% |
| Net Cash from Operations | -354,165 | -194,435 | -82.2% |
| Investing Activities | |||
| Payments To Acquire Marketable Securities | -209,733 | -510,036 | +58.9% |
| Proceeds From Maturity Of Marketable Securities | 383,886 | 497,353 | -22.8% |
| Capital Expenditures | -1,538 | -3,266 | +52.9% |
| Net Cash from Investing | 172,615 | -15,949 | +1182.3% |
| Financing Activities | |||
| Proceeds From Issuance Of Common Stock From At The Market Offering | 226,730 | — | — |
| Proceeds From Stock Plans | 12,209 | 891 | +1270.3% |
| Proceeds From Warrant Exercises | 57 | 1 | +5600.0% |
| Payments Of Deferred Offering Costs | -252 | -18 | -1300.0% |
| Net Cash from Financing | 238,744 | 874 | +27216.2% |
| Amortization of Financing Costs | 237 | — | — |
| Supplemental | |||
| Unpaid Capital Expenditures | 786 | 2,785 | -71.8% |
| Other Cash Flow | |||
| Net Change in Cash | 57,194 | -209,510 | +127.3% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 445,797 | 337,252 | +32.2% |
| Restricted Cash | 4,858 | 3,698 | +31.4% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 445,797 | 337,252 | +32.2% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.